Author Archives: lmo032

New PhD-Coordinator at Department of Clinical Science

Present PhD-Coordinator Kristian Jensen will start a new job on 01.05.2015.  Higher Executive Officer Irene Lavik Hjelmaas will then take over all PhD-related tasks.  Kristian will also be absent between 27.02.2015 – 06.04.2015, so during this period Irene may also be contacted regarding PhD-related inquiries.  Irene may be reached at phone 55 58 88 46 or e-mail  Irene Hjelmaas

Public defence Week 10

Carla FernandesCarla Patrica Duarte Fernandes will have her public defence on Thursday March 5, 2015
Trial lecture: Thursday March 5 2015, kl.09.15
Topic: ”Genomics neurodevelopment and neuropsychiatry – what studies of cognition can tell us about psychosis risk”
Place: Auditoriet, Barneklinikken, Jonas Lies vei 65
Public defence: Thursday March 5 2015, kl.11.15
Place: Auditoriet, Barneklinikken, Jonas Lies vei 65
Title of dissertation: ”A Genetic  study of schizophrenia and bipolar disorder.  A cognitive endophenotype approach”
1st opponent Professor Gary Donohoe, National  University of Ireland
2nd opponent Ph.d. Robert Lyle, Universitetet i Oslo

Press relase

 

 

 

Public defence Week 10

Sivakumaran, DhanasekaranDhanasekaran Sivakumaran will have his public defence on Thursday March 5, 2015
Trial lecture: Thursday March 5, 2015,kl. 09:15
Topic: ”Tuberculosis and latent tuberculosis infection: dignostic strategies in high- and low endemic settings”
Place: Audtorium 1, Bygg for biologiske basalfag
Public defence: Thursday March 5, 2015 kl. 11.15
Place: Audtorium 1, Bygg for biologiske basalfag
Title of dissertation: ”Biomarkersof mycobacterium tuberculosis infection and disease in children in Southern India”
1st  Opponent: MD, Ph.D. Søren Tetens Hoff, Statens Serum Institute, København, Danmark
2nd. Opponent :Ph.D Ulf R. Dahle Folkehelseinstituttet

 Press relase

 

Public defence Week 10

Jan Anker JahnsenJan Anker Jahnsen will have his public defence on Friday March 6, 2015
Trial lecture: Thursday March 5, 2015, 15.15
Topic: ”Topogy and pharmacological importance of ionotropic glutamate channels (NMDA and AMPA receptors)”
Place: Auditorium 1, Bygg for Biologiske basalfag
Public defence: Friday March 6, 2015, 10.15
Place: Audtorium 1, Bygg for biologiske basalfag
Title of dissertation: ”Predicted signal peptides, and the role of the N-terminal tail, at the monoamine G-protein coupled receptors 5-HT 2C and a 2c”
1st  Opponent: Proffesor Dan Larhammar, Uppsala Universitet, Sverige
2nd. Opponent : Professor emeritus Ole Jacob Broch, Bergen

 Press relase

 

Verify publications in CRIStin

This is a reminder to all scientific employees that they verify that publications from 2014 are registered in CRIStin.  The institute’s deadline for registering publications is 27.02.2015.  The scientific employee is responsible for adding publications that are missing, but the administration may assist if you encounter any problems (send an e-mail to Kristian Jensen) Click here for information on how to add publications (in Norwegian)

Cristin-org-200

The strategy seminar

Eystein HusebyeNext week K2’s research group leaders and the heads of the teaching sections will meet for a strategy seminar.  A main topic will be the organization of the institute.  Quite a lot works well at the 2-year old K2, and I want to highlight the administrative services as a good example.  Less successful is the dividing of the organizational structure into teaching sections and research groups.  We wish to discuss the organizational structure as a whole with the aim of achieving a more operational and efficient institute structure which involves the research group leaders to a larger extent than before.

 Another main issue is collaboration with other institutions.  I wish for a tighter and more dynamic collaboration with the hospital sections attached to K2.  This collaboration is currently probably working best at the smaller and professionalized departments such as the Department of Gynecology and Obstetrics, The Children’s Clinic, Medical Genetics and Rheumatology.  However, a large potential for improvement exists regarding the collaboration with very large departments such as, for instance, the Department of Internal Medicine and Department of Heart Disease.  If all leaders at the hospital and the institutes were represented in each other’s leader groups, then this could perhaps promote this collaboration.  Here we can learn from the exciting solutions they have in Trondheim, where hospital and university leadership collaborate very closely.

 Nothing has been decided in advance.  Thus, I hope for a creative and constructive seminar.

 Eystein Husebye
Head of Department